Fundraising FoxMireca Medicines
Tübingen, DE · 1 known investors
Find your way into Mireca Medicines
79 people in our graph share verified history with the Mireca Medicines team — schools, employers, funds. One of them is your warm intro.
Lars Jannick Johansenunlockedknows Barbara Brunnhuber · together at University of Vienna (overlapped)
×11knows the team · via University of Vienna
Mireca develops treatments for rare, inherited retinal degenerations based on scientific research originating from the EU-funded DRUGSFORD project. The company translates basic research into therapeutic candidates targeting photoreceptor degeneration diseases such as retinitis pigmentosa and achromatopsia.
Founders & leadership
PF
Prof. François Paquet-DurandScientific Founder
BB
Barbara BrunnhuberChief Executive OfficerBarbara Brunnhuber holds degrees in chemistry and economics and has held multiple roles at the interface of science and business in biotech and medtech. She is Chief Executive Officer of Mireca Medicines, which develops treatments for rare inherited retinal degenerations.
Investors · 1
Frequently asked questions
- What does Mireca Medicines do?
- Mireca develops treatments for rare, inherited retinal degenerations based on scientific research originating from the EU-funded DRUGSFORD project. The company translates basic research into therapeutic candidates targeting photoreceptor degeneration diseases such as retinitis pigmentosa and achromatopsia.
- Who founded Mireca Medicines?
- Mireca Medicines was founded by Prof. François Paquet-Durand.
- Who are Mireca Medicines's investors?
- Mireca Medicines's investors include LU Innovation.
- Where is Mireca Medicines headquartered?
- Mireca Medicines is headquartered in Tübingen, DE.